Inhibikase Therapeutics, Inc. (IKT) Earnings
NASDAQ·Healthcare·Biotechnology
$1.51
—
Mkt Cap $200.93M
EPS — Estimate vs Actual
Mkt Cap
$200.93M
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$0.54
NASDAQ·Healthcare·Biotechnology
$1.51
—
Mkt Cap $200.93M
Mkt Cap
$200.93M
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$0.54